Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny

From Xconomy VC, Deals, & Startups
May 18, 2017 - 12:01pm
Chris Garabedian, a veteran biotech executive who helped turn Sarepeta Therapeutics around before his controversial exit in 2015, has returned to the life sciences scene—this time with a new venture to form some biotech startups and help others find their footing. Garabedian is the chairman and CEO of a new Boston-based life sciences accelerator called […]

Continue reading this article »